Clinical trials

  • PIVEKIMAB SUNIRINE for Acute myeloid leukemia | Relapsed or refractory acute myeloid leukemia
  • Tofacitinib for Juvenile idiopathic arthritis
  • VEMURAFENIB for Hairy cell leukemia
  • Zoledronic acid for Primary hyperparathyroidism
  • IMG-007 for Atopic dermatitis
  • EXENATIDE for Parkinson's disease
  • DATOPOTAMAB DERUXTECAN for Non-small cell lung cancer (non-squamous, advanced/metastatic) | TROP2-positive non-small cell lung cancer without actionable genomic alterations
  • ceftazidime, avibactam for Bloodstream infection | Hospital-acquired pneumonia | Ventilator-associated pneumonia
  • MEPIVACAINE HYDROCHLORIDE for Respiratory disease
  • Halobetasol propionate for Plaque Psoriasis
  • GEPOTIDACIN for Urinary tract infection
  • ELACESTRANT DIHYDROCHLORIDE for Breast cancer